Oncotarget

Research Papers:

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma

Wei-Ming Li, Chun-Nung Huang, Hung-Lung Ke, Ching-Chia Li, Yu-Ching Wei, Hsin-Chih Yeh, Lin-Li Chang, Chun-Hsiung Huang, Peir-In Liang, Bi-Wen Yeh, Ti-Chun Chan, Chien-Feng Li _ & Wen-Jeng Wu

PDF  |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2016; 7:77777-77792. https://doi.org/10.18632/oncotarget.12795

Metrics: PDF 739 views  |   HTML 778 views  |   ?  


Abstract

Wei-Ming Li1,2,3,4, Chun-Nung Huang2,3, Hung-Lung Ke2,3, Ching-Chia Li2,3,5, Yu-Ching Wei6, Hsin-Chih Yeh2,3,5, Lin-Li Chang1,7, Chun-Hsiung Huang1,2,3, Peir-In Liang8, Bi-Wen Yeh2,3, Ti-Chun Chan9, Chien-Feng Li9,10,11,12,13, Wen-Jeng Wu1,2,3,5,14,15,16

1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

2Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

3Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

4Department of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan

5Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

6Department of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

7Department of Microbiology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

8Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

9Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan

10Departments of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan

11National Cancer Research Institute, National Health Research Institutes, Tainan, Taiwan

12Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

13Department of Internal Medicine and Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

14Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan

15Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung, Taiwan

16Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan

Correspondence to:

Chien-Feng Li, email: angelo.p@yahoo.com.tw

Wen-Jeng Wu, email: wejewu@kmu.edu.tw

Keywords: urothelial carcinoma, transcriptome, MCM10, prognosis

Received: July 20, 2016     Accepted: October 12, 2016     Published: October 21, 2016

ABSTRACT

Urothelial carcinoma (UC) occurs in the upper urinary tract (UTUC) and the urinary bladder (UBUC). The molecular pathogenesis of UC has not been fully elucidated. Through data mining of a published transcriptome of UBUC (GSE31684), we identified Minichromosome Maintenance Complex Component 2 (MCM2) and MCM10 as the two most significantly upregulated genes in UC progression among the MCM gene family, the key factors for the initiation of DNA replication. To validate the clinical significance of MCM2 and MCM10, immunohistochemistry, evaluated by H-score, was used in a pilot study of 50 UTUC and 50 UBUC samples. Only a high expression level of MCM10 predicted worse disease-specific survival (DSS) and inferior metastasis-free survival (MeFS) for both UTUC and UBUC. Correspondingly, evaluation of MCM10 mRNA expression in 36 UTUCs and 30 UBUCs showed significantly upregulated levels in high stage UC, suggesting its role in tumor progression. Evaluation of 340 UTUC and 296 UBUC tissue samples, respectively, demonstrated that high MCM10 immunoexpression was significantly associated with advanced primary tumors, nodal status, and the presence of vascular invasion in both groups of UCs. In multivariate Cox regression analyses, adjusted for standard clinicopathological features, MCM10 overexpression was independently associated with DSS (UTUC hazard ratio [HR]=2.401, P = 0.013; UBUC HR=4.323, P=0.001) and with MeFS (UTUC HR=3.294, P<0.001; UBUC HR=1.972, P=0.015). In vitro, knockdown of MCM10 gene significantly suppressed cell proliferation in both J82 and TCCSUP cells. In conclusion, MCM10 overexpression was associated with unfavorable clinicopathological characteristics and independent negative prognostic effects, justifying its potential theranostic value in UC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12795